Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREOnce-a-day, broad spectrum antibiotic therapy containing orbifloxacin, ideal for cats and small dogs.
LEARN MORE